Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €37.39 EUR
Change Today +0.185 / 0.50%
Volume 0.0
OLY1 On Other Exchanges
As of 2:19 AM 11/26/15 All times are local (Market data is delayed by at least 15 minutes).

olympus corp (OLY1) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/23/15 - €38.22
52 Week Low
09/29/15 - €26.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OLYMPUS CORP (OLY1)

Related News

No related news articles were found.

olympus corp (OLY1) Related Businessweek News

View More BusinessWeek News

olympus corp (OLY1) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

31,540 Employees
Last Reported Date: 06/26/15
Founded in 1919

olympus corp (OLY1) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥98.6M
Compensation as of Fiscal Year 2015.

olympus corp (OLY1) Key Developments

Olympus Corporation Launches CKX53 Microscope

Olympus Corporation has announced that its Scientific Solutions Business has launched the CKX53 microscope designed to support cell culturing. The CKX53 features clear images and efficient operation. The microscope is available beginning December 2, 2015. In the fields of regenerative medicine and drug discovery, different types of cells, such as iPS and other stem cells, are produced for research use through a continuous cell culture process. Inverted microscopes designed for live cell observation are used during this process to periodically check cell growth or to capture images of cells as needed. To facilitate the cell culture process, Olympus engineered the advanced and customizable IX3 series of microscopes as well as the compact and lightweight CKX series for quick and easy observation. The new CKX53 culture microscope is the successor to the CKX41 and CKX31, making it the first full model change in 13 years. While the CKX53 maintains the same excellent optical performance that the CKX series is known for, the new model delivers clearer images and faster startup to features such as a new phase contrast system and LED light source. The CKX53 is approximately 20% lighter than the previous model making it easier to operate for more efficient cell culturing. Main Features include: reliable color reproducibility with an LED light source; compact and lightweight body with user-friendly operation; and supports quick cell observation with a new phase contrast system. In place of the halogen bulbs used on previous models, the CKX53 uses an LED light source with a color chosen specifically to suit cell imaging. The LED light source produces crisp cell images with good color reproducibility even when changes are made to the brightness around the da viewing field. Furthermore, because the LED light source can be used as soon as the power is turned on, it provides faster cell observation. Because the CKX53 is approximately 20% lighter than the previous model, it is easier to move the microscope round the laboratory and place it on a clean bench when performing cell observation under aseptic conditions. The microscope is designed for efficient operation, with the controls conveniently placed around the power switch. The new phase contrast observation system available on the CKX53 features 4X, 10X, 20X, or 40X magnification using the same ring slit (compared to 10X, 20X, and 40X on the previous model). This provides simple and efficient cell observation at different magnifications without adjustment.

The Serious Fraud Office Drops Fraud Charges against Olympus and Gyrus Group

The Serious Fraud Office (SFO) has dropped its fraud charges against Olympus and its subsidiary Gyrus Group marking a win for its lawyers Slaughter and May. The news marks the end of a case launched in 2011 when Olympus's former CEO blew the whistle on £1.06 billion of fraudulent deals. The row hit the High Court last year when Mr. Justice Eder ruled the charges could not be committed by the UK company under audit. The Court of Appeal upheld Eder J's ruling, leading to the SFO decision on November 10, 2015. Slaughters has also bagged an instruction from Rolls-Royce to advise it on the SFO probe into allegations of bribery and corruption at the company. That case is still ongoing.

Olympus Corporation Presents at 10th Annual Daiwa Investment Conference, Nov-10-2015

Olympus Corporation Presents at 10th Annual Daiwa Investment Conference, Nov-10-2015 . Venue: Island Shangri-La, Pacific Place, Supreme Court Road, Admlralty, Hong Kong, Hong Kong.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OLY1:GR €37.39 EUR +0.185

OLY1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $56.46 USD 0.00
CR Bard Inc $187.40 USD +1.16
Smith & Nephew PLC 1,117 GBp +10.00
St Jude Medical Inc $62.97 USD +0.19
Terumo Corp ¥4,000 JPY +35.00
View Industry Companies

Industry Analysis


Industry Average

Valuation OLY1 Industry Range
Price/Earnings 100.0x
Price/Sales 2.0x
Price/Book 4.2x
Price/Cash Flow 37.5x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OLYMPUS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at